Analyst firms · H.C. Wainwright · NVAX
H.C. Wainwright NVAX price target and rating history
Novavax Inc. (NVAX) · Health Care
H.C. Wainwright rates Novavax Inc. (NVAX) Buy with a $10 price target, as of its latest action on Aug 28, 2025. It has published 3 rating actions on NVAX since March 2022, including 0 upgrades and 0 downgrades.
- Current rating
- Buy
- Price target
- $10
- Median target, all firms
- Too few
- Actions on NVAX
- 3
H.C. Wainwright price target on NVAX
Every H.C. Wainwright rating on NVAX
- Aug 28, 2025
- Dec 30, 2022
- Mar 3, 2022
Questions about H.C. Wainwright and NVAX
- What is H.C. Wainwright's price target for NVAX?
- H.C. Wainwright's latest stated price target for Novavax Inc. (NVAX) is $10, from its action on Aug 28, 2025.
- What is H.C. Wainwright's rating on NVAX?
- H.C. Wainwright rates NVAX Buy, a bullish rating, as of Aug 28, 2025.
- When did H.C. Wainwright last change its view on NVAX?
- On Aug 28, 2025, H.C. Wainwright resumes coverage at Buy, price target $10.
More NVAX rating histories
All H.C. Wainwright ratingsNVAX news and filingsEvery analyst firm
From rating actions in the Quantisnow feed. A target holds until the firm states a new one; a reiteration with no target keeps the last one. Not investment advice.